TFE3 and neoplasm with perivascular epithelioid cell differentiation: Even though access to molecular biology has increased since previous reviews, very few cases reported the search for a TFE3 translocation, a TSC1 or TSC2 loss of function mutations or even no FCLN mutation, considered to be the more recent genomic alterations described in PEComas.